EP3209381

4D PHARMA RESEARCH LIMITED
Application Number
EP16804857A
Filing Date
Nov 23, 2016
Status
Revoked
Dec 1, 2023
Grant Date
Nov 14, 2018
External Links
Slate, Register

Biblio Summary

The patent EP3209381B1 was granted on Nov 14, 2018 by 4D Pharma Research Limited The patent is currently Revoked.

The table below shows 2 patent oppositions filed on the patent at EPO, listing each opposing company and filing date. Tracking these filings indicates that the applicant is active in this industry, while opposing companies may be signaling their own interest in competing within the same space. These disputes are essential for insights into competitor actions, patent strategy and emerging technological trends.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BRADY, PAUL ANDREWAug 14, 2019 N.A.
HOFFMANN EITLE PATENT- UND RECHTSANWALTE PARTNERSCHAFTSGESELLSCHAFT MBBAug 14, 2019 N.A.

The table below shows the patents of 4D Pharma Research Limited that have been opposed by other companies.

Patent NumberTitleGrant DateOpposition Count
EP3240554Compositions Comprising Bacterial StrainsJul 31, 20191
EP3209309Compositions Comprising Bacterial StrainsMar 14, 20182

Dossier Documents of the Patent

The documents dossier of the patent at EPO including all essential records in the patent's lifecycle, from filing to grant to oppositions.